BACKGROUND AND PURPOSE: Differences in ischemic stroke between men and women have been mainly attributed to hormonal effects. However, sex differences in immune response to ischemia may exist. We hypothesized that differential expression of X-chromosome genes in blood immune cells contribute to differences between men and women with ischemic stroke. METHODS: RNA levels of 683 X-chromosome genes were measured on Affymetrix U133 Plus2.0 microarrays. Blood samples from patients with ischemic stroke were obtained at ≤ 3 hours, 5 hours, and 24 hours (n=61; 183 samples) after onset and compared with control subjects without symptomatic vascular diseases (n=109). Sex difference in X-chromosome gene expression was determined using analysis of covariance (false discovery rate ≤ 0.05, fold change ≥ 1.2). RESULTS: At ≤ 3, 5, and 24 hours after stroke, there were 37, 140, and 61 X-chromosome genes, respectively, that changed in women; and 23, 18, and 31 X-chromosome genes that changed in men. Female-specific genes were associated with post-translational modification, small-molecule biochemistry, and cell-cell signaling. Male-specific genes were associated with cellular movement, development, cell-trafficking, and cell death. Altered sex specific X-chromosome gene expression occurred in 2 genes known to be associated with human stroke, including galactosidase A and IDS, mutations of which result in Fabry disease and Hunter syndrome, respectively. CONCLUSIONS: There are differences in X-chromosome gene expression between men and women with ischemic stroke. Future studies are needed to decipher whether these differences are associated with sexually dimorphic immune response, repair or other mechanisms after stroke, or whether some of them represent risk determinants.
BACKGROUND AND PURPOSE: Differences in ischemic stroke between men and women have been mainly attributed to hormonal effects. However, sex differences in immune response to ischemia may exist. We hypothesized that differential expression of X-chromosome genes in blood immune cells contribute to differences between men and women with ischemic stroke. METHODS: RNA levels of 683 X-chromosome genes were measured on Affymetrix U133 Plus2.0 microarrays. Blood samples from patients with ischemic stroke were obtained at ≤ 3 hours, 5 hours, and 24 hours (n=61; 183 samples) after onset and compared with control subjects without symptomatic vascular diseases (n=109). Sex difference in X-chromosome gene expression was determined using analysis of covariance (false discovery rate ≤ 0.05, fold change ≥ 1.2). RESULTS: At ≤ 3, 5, and 24 hours after stroke, there were 37, 140, and 61 X-chromosome genes, respectively, that changed in women; and 23, 18, and 31 X-chromosome genes that changed in men. Female-specific genes were associated with post-translational modification, small-molecule biochemistry, and cell-cell signaling. Male-specific genes were associated with cellular movement, development, cell-trafficking, and cell death. Altered sex specific X-chromosome gene expression occurred in 2 genes known to be associated with humanstroke, including galactosidase A and IDS, mutations of which result in Fabry disease and Hunter syndrome, respectively. CONCLUSIONS: There are differences in X-chromosome gene expression between men and women with ischemic stroke. Future studies are needed to decipher whether these differences are associated with sexually dimorphic immune response, repair or other mechanisms after stroke, or whether some of them represent risk determinants.
Authors: Véronique L Roger; Alan S Go; Donald M Lloyd-Jones; Robert J Adams; Jarett D Berry; Todd M Brown; Mercedes R Carnethon; Shifan Dai; Giovanni de Simone; Earl S Ford; Caroline S Fox; Heather J Fullerton; Cathleen Gillespie; Kurt J Greenlund; Susan M Hailpern; John A Heit; P Michael Ho; Virginia J Howard; Brett M Kissela; Steven J Kittner; Daniel T Lackland; Judith H Lichtman; Lynda D Lisabeth; Diane M Makuc; Gregory M Marcus; Ariane Marelli; David B Matchar; Mary M McDermott; James B Meigs; Claudia S Moy; Dariush Mozaffarian; Michael E Mussolino; Graham Nichol; Nina P Paynter; Wayne D Rosamond; Paul D Sorlie; Randall S Stafford; Tanya N Turan; Melanie B Turner; Nathan D Wong; Judith Wylie-Rosett Journal: Circulation Date: 2010-12-15 Impact factor: 29.690
Authors: Xia Yang; Eric E Schadt; Susanna Wang; Hui Wang; Arthur P Arnold; Leslie Ingram-Drake; Thomas A Drake; Aldons J Lusis Journal: Genome Res Date: 2006-07-06 Impact factor: 9.043
Authors: Glen C Jickling; Xinhua Zhan; Bradley P Ander; Renée J Turner; Boryana Stamova; Huichun Xu; Yingfang Tian; Dazhi Liu; Ryan R Davis; Paul A Lapchak; Frank R Sharp Journal: BMC Genomics Date: 2010-04-21 Impact factor: 3.969
Authors: Arthur M Pancioli; Joseph Broderick; Thomas Brott; Thomas Tomsick; Jane Khoury; Judy Bean; Gregory del Zoppo; Dawn Kleindorfer; Daniel Woo; Pooja Khatri; John Castaldo; James Frey; James Gebel; Scott Kasner; Chelsea Kidwell; Thomas Kwiatkowski; Richard Libman; Richard Mackenzie; Phillip Scott; Sidney Starkman; R Jason Thurman Journal: Stroke Date: 2008-09-04 Impact factor: 7.914
Authors: Alex Förster; Achim Gass; Rolf Kern; Marc E Wolf; Caroline Ottomeyer; Katrin Zohsel; Michael Hennerici; Kristina Szabo Journal: Stroke Date: 2009-05-21 Impact factor: 7.914
Authors: Boryana S Stamova; Michelle Apperson; Wynn L Walker; Yingfang Tian; Huichun Xu; Peter Adamczy; Xinhua Zhan; Da-Zhi Liu; Bradley P Ander; Isaac H Liao; Jeffrey P Gregg; Renee J Turner; Glen Jickling; Lisa Lit; Frank R Sharp Journal: BMC Med Genomics Date: 2009-08-05 Impact factor: 3.063
Authors: Deepak Acharya; Renzo Loyaga-Rendon; Charity J Morgan; Kara A Sands; Salpy V Pamboukian; Indranee Rajapreyar; William L Holman; James K Kirklin; José A Tallaj Journal: JACC Heart Fail Date: 2017-10 Impact factor: 12.035
Authors: Yingfang Tian; Boryana Stamova; Glen C Jickling; Huichun Xu; Dazhi Liu; Bradley P Ander; Cheryl Bushnell; Xinhua Zhan; Renee J Turner; Ryan R Davis; Piero Verro; William C Pevec; Nasim Hedayati; David L Dawson; Jane Khoury; Edward C Jauch; Arthur Pancioli; Joseph P Broderick; Frank R Sharp Journal: Gend Med Date: 2012-02-24